Effect of Chinese herbal medicine for patients with benign thyroid nodules in adults: A protocol for systematic review and meta-analysis.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
26 Feb 2021
26 Feb 2021
Historique:
received:
13
01
2021
accepted:
14
01
2021
entrez:
5
3
2021
pubmed:
6
3
2021
medline:
17
3
2021
Statut:
ppublish
Résumé
Thyroid nodules (TN) are discrete lesions within the thyroid gland and are a common clinical problem detected in 19% to 68% of people. TN are more common as age increases and occur more frequently in women. TN can cause pressure symptoms, cosmetic complaints, and thyroid dysfunction. Treatment for benign thyroid nodules includes thyroid hormone therapy, surgery, radioiodine treatment, percutaneous ethanol injection therapy, and laser or radiofrequency treatment to shrink nodules. In China and many other countries, doctors use Chinese herbal medicines (CHM) to treat TN. However, systematic review and meta-analysis has not been found to assess the effects and safety of CHM in curing TN at present. Hence, the systematic review is conducted to scientifically and methodically evaluate the value of its effectiveness and safety of CHM on TN. Literatures related to CHM for TN from the establishment of the database to November 2020 will be retrieved from the following databases: PubMed, Excerpta Medica Database (EMBASE), MEDLINE, Web of Science, Cochrane Library, SpringerLink, WHO International Clinical Trials Registry Platform (ICTRP), Wanfang Database, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature Database (CBM), and Chinese Scientific Journal Database (VIP). There are no language restrictions for retrieving literatures. Case reports, animal studies, editorials, expert opinions, reviews without original data, and studies on pediatric population were excluded. Eligible randomized clinical trials (RCTs) evaluating the effectiveness and safety of CHM in TN patients will be put in the study including nodule volume reduction ≥50%, pressure symptoms, cosmetic complaints, quality of life, and adverse events. By scanning the titles, abstracts and full texts, 2 reviewers will independently select studies, extract data, and assess the quality of study. Meta-analysis of RCTs will be conducted using Review Manager 5.1 software. The results will be presented as risk ratio for dichotomous data, and standardized or weighted mean difference for continuous data. This study will provide high-quality available evidence for the treatment of TN with CHM based on nodule volume reduction ≥50%, pressure symptoms, cosmetic complaints, quality of life, and adverse events. The systematic review will to evaluate the efficacy of CHM in treating benign thyroid nodules in adults and provide evidence for clinicians. INPLASY2020120093.
Sections du résumé
BACKGROUND
BACKGROUND
Thyroid nodules (TN) are discrete lesions within the thyroid gland and are a common clinical problem detected in 19% to 68% of people. TN are more common as age increases and occur more frequently in women. TN can cause pressure symptoms, cosmetic complaints, and thyroid dysfunction. Treatment for benign thyroid nodules includes thyroid hormone therapy, surgery, radioiodine treatment, percutaneous ethanol injection therapy, and laser or radiofrequency treatment to shrink nodules. In China and many other countries, doctors use Chinese herbal medicines (CHM) to treat TN. However, systematic review and meta-analysis has not been found to assess the effects and safety of CHM in curing TN at present. Hence, the systematic review is conducted to scientifically and methodically evaluate the value of its effectiveness and safety of CHM on TN.
METHODS
METHODS
Literatures related to CHM for TN from the establishment of the database to November 2020 will be retrieved from the following databases: PubMed, Excerpta Medica Database (EMBASE), MEDLINE, Web of Science, Cochrane Library, SpringerLink, WHO International Clinical Trials Registry Platform (ICTRP), Wanfang Database, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature Database (CBM), and Chinese Scientific Journal Database (VIP). There are no language restrictions for retrieving literatures. Case reports, animal studies, editorials, expert opinions, reviews without original data, and studies on pediatric population were excluded. Eligible randomized clinical trials (RCTs) evaluating the effectiveness and safety of CHM in TN patients will be put in the study including nodule volume reduction ≥50%, pressure symptoms, cosmetic complaints, quality of life, and adverse events. By scanning the titles, abstracts and full texts, 2 reviewers will independently select studies, extract data, and assess the quality of study. Meta-analysis of RCTs will be conducted using Review Manager 5.1 software. The results will be presented as risk ratio for dichotomous data, and standardized or weighted mean difference for continuous data.
RESULT
RESULTS
This study will provide high-quality available evidence for the treatment of TN with CHM based on nodule volume reduction ≥50%, pressure symptoms, cosmetic complaints, quality of life, and adverse events.
CONCLUSION
CONCLUSIONS
The systematic review will to evaluate the efficacy of CHM in treating benign thyroid nodules in adults and provide evidence for clinicians.
INPLASY REGISTRATION NUMBER
UNASSIGNED
INPLASY2020120093.
Identifiants
pubmed: 33663069
doi: 10.1097/MD.0000000000024591
pii: 00005792-202102260-00032
pmc: PMC7909165
doi:
Substances chimiques
Drugs, Chinese Herbal
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e24591Subventions
Organisme : Innovative Research Group Project of the National Natural Science Foundation of China
ID : 81873204
Informations de copyright
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no conflicts of interests to disclose.
Références
Cooper DS, Doherty GM, Haugen BR, et al. The American Thyroid Association (ATA) Guidelines Taskforce. Management guidelines for patients with thyroid nodules and diferentiated thyroid cancer. Thyroid 2006;16:109–42.
Chinese Society of Endocrinology ’Guideline on diagnosis and treatment thyroid disease’ writing group. Guideline on diagnosis and treatment thyroid disease. Chin J Integr Med 2008;47:867–8.
Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15year study of the incidence of thyroid malignancy. Ann Intern Med 1968;69:537–40.
Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7:481–93.
Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126:226–31.
Guth S, Theune U, Aberle J, et al. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009;39:699–706.
Hegedus L. Clinical practice. The thyroid nodule. NEJM 2004;351:1764–71.
Lansford CD, Teknos TN. Evaluation of the thyroid nodule. Cancer Control 2006;13:89–98.
Wu W, Yin D, Yang W, et al. Chinese herbal medicines for benign thyroid nodules in adults. Cochrane Database Syst Rev 2014. CD010492doi: 10.1002/14651858.CD010492.pub2. PMID: 24596045.
doi: 10.1002/14651858.CD010492.pub2.
Mandel SJ. A 64-year-old woman with a thyroid nodule. JAMA 2004;292:2632–42.
Kroneberg HM, Melmed S, Polonsky KS. Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, et al. Thyroid. Williams Textbook of Endocrinology. Vol.13 11th EdPhiladelphia: Saunders Elsevier; 2008. 414.
Cooper DS, Doherty GM, Haugen BR, et al. The American Thyroid Association (ATA) Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109–42.
Cohen R, Campos JM, Salaün C, et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. J Clin Endocrinol Metab 2000;85:919–22.
American Association of Clinical Endocrinologists and Associzione Medici Endocrinologi. Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrine Practice 2006;12:78.
Haugen BR, Alexander EK, Bible KC, et al. American Thyroid Association management guidelines for adults patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1–33.
Henrichsen TL, Reading CC. Thyroid ultrasonography. Part 2: nodules. Radiol Clin North Am 2011;49:417–24.
Moon WJ, Baek JH, Jung SL, et al. Ultrasonography and the ultrasound-based management of thyroid nodules. Korean J Radiol 2011;12:1–4. DOI: 10.3348/kjr.2011.12.1.1.
doi: 10.3348/kjr.2011.12.1.1
Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008;36:425–37.
Djokomoeljanto R. Kelainan kelenjar tiroid: fokus pada terapi enyakit Graves dan nodul tiroid. In: Pengelolaan secara rasional dan terkini di bidang endokrinologi. National Symposium of Indonesian Society of Endocrinology. 2004;Padang: West Sumatra branch of Indonesian Society of Endocrinology, 32–57.
Burman KD, Wartofsky L. Thyroid nodules. New Engl J Med 2015;373:2347–56.
Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 2007;36:707–35.
Mazzaferri EL. Management of a solitary thyroid nodule. New Engl J Med 1993;328:553–9.
Shchlumberger M, Pacini F. Thyroid Tumors. Paris: Nucleon; 2006.
Henrichsen TL, Reading CC. Thyroid ultrasonography. Part 2: odules. Radiol Clin North Am 2011;49:417–24.
Sakarofas GH, Peros G. Thyroid nodule: a potential malignant lesion; optimal management from a surgical perspective. Cancer Treat Rev 2006;32:191–202.
Zhang HH, Yang HJ, Ding Y. Influence of serum containing Neixiaolianqiao Pills on proliferation and secretion of human nodular goiter cells cultured in vitro. J Beijing Univ Tradit Chin Med 2006;29:482–5.
Sun JH, Li Y, Xu H, et al. Clinical study on compound radices salviae in treating the early diabetic retinopathy [Fufang Danshen Di Wan zhi liao zao qi tang niao bing xing shi wang mo bing bian de lin chuang yan jiu]. Hebei Bei Fang Xue Yuan Xue Bao [Journal of Herbei North University (Medical Edition)] 2007;24:28–30.
Song YM, Lv PL, Tong JA, et al. Puerarin acupuncture therapy around eyes for 50 cases patients with type 2 diabetic retinopathy [Gegensu yan zhou xue wei zhu she zhi liao er xing tang niao bing xing shi wang mo bing bian 50 li]. Shaanxi J Tradit Chin Med 2006;27:472–4.
Chen S, Sun B, Zheng H, et al. Clinical research progress of traditional Chinese medicine in the treatment of thyroid nodules. Med Recapitulate 2017;23: 3903–3906+3911.
Li Jinhong. Study on the regularity of effective compound prescription of traditional Chinese Medicine in the treatment of thyroid nodules. Yunnan J Tradit Chin Med Materia Medica 2017;38:98–9. DOI:10.3969/j.issn.1007-2349.2017.02.041.
doi: 10.3969/j.issn.1007-2349.2017.02.041
Feng Wei. Clinical study of Xiaoying Sanjie Fang in the treatment of thyroid nodules. Nanjing Univ Tradit Chin Med 2015.
Xie J. Clinical study on the treatment of thyroid nodules with Xiaogong Ruanjian decoction Guangdong. Guangzhou Univ Tradit Chin Med 2011.
Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2016;354:i4086.